Skip to main content
Fig. 2 | Journal of Nanobiotechnology

Fig. 2

From: Anti-ICAM-1 antibody-modified nanostructured lipid carriers: a pulmonary vascular endothelium-targeted device for acute lung injury therapy

Fig. 2

The cytotoxicity and cellular uptake of NLCs against EAhy926 cells. a The cytotoxicity of formulated blank NLCs (i) and dexamethasone-loaded NLCs (ii) against activated EAs. b Cellular uptake of dexamethasone-loaded NLCs in activated EAs detected by fluorescence microscope (i) (bar = 100 μm) and the semi-quantitative analysis of the images using software ‘‘Image J’’ (ii). c Cellular uptake of dexamethasone-loaded NLCs in activated EAs detected by flow cytometer. The data represent the mean ± SD (n = 3)

Back to article page